COVID-19 is the respiratory illness caused by the novel coronavirus, SARS-CoV-2. Cytokine storm appears to be a factor in COVID-19 mortality. Echinacea species have been used historically for immune modulation. A previous rapid review suggested that Echinacea supplementation may decrease the levels of pro-inflammatory cytokines involved in cytokine storm. The objective of the present systematic review was to identify all research that has assessed changes in levels of cytokines relevant to cytokine storm in response to administration of Echinacea supplementation. The following databases were searched: Medline (Ovid), AMED (Ovid), CINAHL (EBSCO), EMBASE (Ovid). Title and abstract screening, full text screening, and data extraction were completed in duplicate using a piloted extraction template. Risk of bias assessment was completed. Qualitative analysis was used to assess for trends in cytokine level changes. The search identified 279 unique publications. After full text screening, 105 studies met criteria for inclusion including 13 human studies, 24 animal studies, and 71 in vitro or ex vivo studies. The data suggest that Echinacea supplementation may be associated with a decrease in the pro-inflammatory cytokines IL-6, IL-8, and TNF, as well as an increase in the anti-inflammatory cytokine IL-10. The risk of bias in the included studies was generally high. While there is currently no substantive research on the therapeutic effects of Echinacea in the management of either cytokine storm or COVID-19, the present evidence related to the herb’s impact on cytokine levels suggests that further research may be warranted in the form of a clinical trial involving patients with COVID-19. Highlights • Modulation of the immune system has been identified as a possible management strategy in severe COVID-19. • A systematic review of all studies assessing changes in cytokine levels following Echinacea supplementation was undertaken. • Echinacea supplementation may decrease the pro-inflammatory cytokines IL-6, IL-8, and TNF. • Echinacea supplementation may increase the anti-inflammatory cytokine IL-10. • Clinical trials assessing the effectiveness of Echinacea in the treatment of cytokine storm in COVID-19 may be warranted.
【저자키워드】 COVID-19, Cytokine storm, COVID-19, Coronavirus disease 2019, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, cytokine, herbal medicine, Cytokine release syndrome, breath, IFN, interferon, Echinacea, ARDS, acute respiratory distress syndrome, CCL, C–C motif ligand chemokine, CSF, Colony-stimulating factor, GM-CSF, granulocyte-macrophage colony-stimulating factor, IL, interleukin, MCP, monocyte chemoattractant protein, MIP, macrophage inflammatory protein, SARS, Severe acute respiratory syndrome, TFN, tumor necrosis factor, 【초록키워드】 Treatment, SARS-CoV-2, Cytokine storm, clinical trial, Cytokines, Trial, severe COVID-19, IL-6, clinical trials, systematic review, Respiratory illness, cytokine, immune system, in vitro, database, immune modulation, Novel coronavirus, clinical, management, Research, Effectiveness, IL-8, pro-inflammatory cytokines, IL-10, respiratory, Echinacea, cytokine levels, TNF, Evidence, administration, COVID-19 mortality, criteria, qualitative analysis, changes, Ex vivo, Factor, Abstract, modulation, CINAHL, data extraction, title, therapeutic effects, Highlights, therapeutic effect, pro-inflammatory cytokine, AMED, OVID, while, anti-inflammatory cytokine, decrease, identify, was used, caused, involved, appear, changes in, unique, suggested, increase in, cytokine level, for inclusion, patients with COVID-19, risk of bia, 【제목키워드】 cytokine, Effect,